EFFECT OF INTRAVENOUS ENALAPRILAT IN MODERATE AND SEVERE SYSTEMIC HYPERTENSION

被引：25

作者：

RUTLEDGE, J

AYERS, C

DAVIDSON, R

DIPETTE, D

GUTHRIE, G

FISHER, M

SCHWARTZ, S

RUCINSKA, E

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1988年 / 62卷 / 16期

关键词：

D O I：

10.1016/0002-9149(88)90549-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1062 / 1067

页数：6

共 9 条

[1]

AJAIJI AA, 1986, BR J CLIN PHARM, V21, P349

[2] HORMONAL AND METABOLIC EFFECTS OF ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - POSSIBLE DIFFERENCES BETWEEN ENALAPRIL AND CAPTOPRIL [J].

ATLAS, SA ;

CASE, DB ;

YU, ZY ;

LARAGH, JH .

AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2A) :13-17

[3] RACIAL-DIFFERENCES IN PRESSURE, VOLUME AND RENIN INTERRELATIONSHIPS IN ESSENTIAL HYPERTENSION [J].

CHRYSANT, SG ;

DANISA, K ;

KEM, DC ;

DILLARD, BL ;

SMITH, WJ ;

FROHLICH, ED .

HYPERTENSION, 1979, 1 (02) :136-141

[4] ENALAPRILAT, AN INTRAVENOUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN HYPERTENSIVE CRISES [J].

DIPETTE, DJ ;

FERRARO, JC ;

EVANS, RR ;

MARTIN, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) :199-204

[5]

GROSS DM, 1981, J PHARMACOL EXP THER, V216, P552

[6] INTRAVENOUS FUROSEMIDE TEST - SIMPLE WAY TO EVALUATE RENIN RESPONSIVENESS [J].

KAPLAN, NM ;

KEM, DC ;

HOLLAND, OB ;

KRAMER, NJ ;

HIGGINS, J ;

GOMEZSANCHEZ, C .

ANNALS OF INTERNAL MEDICINE, 1976, 84 (06) :639-645

[7] BLOOD-PRESSURE RESPONSE TO ENALAPRILIC ACID IN ESSENTIAL-HYPERTENSION - DOSE-RESPONSE AND EFFECT OF PRE-TREATMENT WITH FUROSEMIDE [J].

NAVIS, GJ ;

DEJONG, PE ;

DONKER, AJM ;

VANDERHEM, GK ;

DEZEEUW, D .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (01) :9-15

[8] ENALAPRILAT IN HYPERTENSIVE EMERGENCIES [J].

STRAUSS, R ;

GAVRAS, I ;

VLAHAKOS, D ;

GAVRAS, H .

JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (01) :39-43

[9]

TILL A E, 1982, Clinical Pharmacology and Therapeutics, V31, P275

← 1 →